Centene Corporation $CNC Stock Holdings Increased by Pallas Capital Advisors LLC

Pallas Capital Advisors LLC lifted its holdings in Centene Corporation (NYSE:CNCFree Report) by 173.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 64,690 shares of the company’s stock after purchasing an additional 41,055 shares during the quarter. Pallas Capital Advisors LLC’s holdings in Centene were worth $2,308,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of CNC. Addison Advisors LLC increased its stake in Centene by 455.6% during the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after buying an additional 606 shares during the period. State of New Jersey Common Pension Fund D boosted its holdings in shares of Centene by 9.7% in the third quarter. State of New Jersey Common Pension Fund D now owns 183,393 shares of the company’s stock valued at $6,543,000 after acquiring an additional 16,199 shares in the last quarter. PNC Financial Services Group Inc. increased its stake in shares of Centene by 43.8% during the third quarter. PNC Financial Services Group Inc. now owns 79,796 shares of the company’s stock valued at $2,847,000 after acquiring an additional 24,301 shares during the period. GF Fund Management CO. LTD. raised its holdings in Centene by 6.4% during the third quarter. GF Fund Management CO. LTD. now owns 14,017 shares of the company’s stock worth $500,000 after purchasing an additional 849 shares in the last quarter. Finally, TT Capital Management LLC acquired a new stake in Centene in the third quarter worth approximately $504,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Stock Up 3.4%

CNC stock opened at $40.53 on Tuesday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.08. The firm has a market capitalization of $19.92 billion, a P/E ratio of -2.98, a P/E/G ratio of 0.90 and a beta of 0.48. Centene Corporation has a 52-week low of $25.08 and a 52-week high of $66.03. The company’s 50 day simple moving average is $42.18 and its 200-day simple moving average is $36.55.

Centene (NYSE:CNCGet Free Report) last posted its quarterly earnings data on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, topping the consensus estimate of ($1.22) by $0.03. The firm had revenue of $49.73 billion for the quarter, compared to analysts’ expectations of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The company’s quarterly revenue was up 21.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, equities research analysts anticipate that Centene Corporation will post 6.86 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Oppenheimer reissued an “outperform” rating and issued a $45.00 price objective on shares of Centene in a research note on Thursday, October 30th. Wall Street Zen cut shares of Centene from a “buy” rating to a “hold” rating in a research report on Sunday. Wells Fargo & Company set a $43.00 price objective on shares of Centene and gave the company an “equal weight” rating in a research report on Wednesday, January 7th. Robert W. Baird boosted their target price on shares of Centene from $28.00 to $36.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Finally, JPMorgan Chase & Co. raised their target price on shares of Centene from $38.00 to $45.00 and gave the stock a “neutral” rating in a report on Thursday, January 22nd. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $41.81.

View Our Latest Analysis on CNC

Centene Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Recommended Stories

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.